NM_024675.4:c.232G>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_024675.4(PALB2):​c.232G>A​(p.Val78Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,609,794 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V78A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 1 hom. )

Consequence

PALB2
NM_024675.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:15

Conservation

PhyloP100: 0.206

Publications

19 publications found
Variant links:
Genes affected
PALB2 (HGNC:26144): (partner and localizer of BRCA2) This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008]
PALB2 Gene-Disease associations (from GenCC):
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • PALB2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia complementation group N
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • pancreatic cancer, susceptibility to, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07516721).
BP6
Variant 16-23636314-C-T is Benign according to our data. Variant chr16-23636314-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 126647.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024675.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALB2
NM_024675.4
MANE Select
c.232G>Ap.Val78Ile
missense
Exon 4 of 13NP_078951.2
PALB2
NM_001407296.1
c.172G>Ap.Val58Ile
missense
Exon 3 of 12NP_001394225.1
PALB2
NM_001407297.1
c.232G>Ap.Val78Ile
missense
Exon 4 of 12NP_001394226.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALB2
ENST00000261584.9
TSL:1 MANE Select
c.232G>Ap.Val78Ile
missense
Exon 4 of 13ENSP00000261584.4Q86YC2
PALB2
ENST00000568219.5
TSL:1
c.-654G>A
5_prime_UTR
Exon 4 of 13ENSP00000454703.2H3BN63
PALB2
ENST00000561514.3
TSL:5
c.238G>Ap.Val80Ile
missense
Exon 4 of 13ENSP00000460666.3A0AA52I2C1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
151812
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000114
AC:
28
AN:
246636
AF XY:
0.000142
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000295
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000243
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000187
AC:
272
AN:
1457982
Hom.:
1
Cov.:
31
AF XY:
0.000192
AC XY:
139
AN XY:
725102
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33416
American (AMR)
AF:
0.0000226
AC:
1
AN:
44328
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26072
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39540
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85346
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53262
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.000235
AC:
261
AN:
1110044
Other (OTH)
AF:
0.000166
AC:
10
AN:
60222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
151812
Hom.:
0
Cov.:
32
AF XY:
0.0000674
AC XY:
5
AN XY:
74130
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41326
American (AMR)
AF:
0.00
AC:
0
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4800
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10526
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67972
Other (OTH)
AF:
0.000480
AC:
1
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000179
Hom.:
0
Bravo
AF:
0.000181
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000140
AC:
17

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
3
not provided (5)
-
-
4
Familial cancer of breast (4)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
2
not specified (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Malignant tumor of breast (1)
-
-
1
PALB2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
2.1
DANN
Benign
0.32
DEOGEN2
Benign
0.10
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.46
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.075
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.21
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.0040
Sift
Benign
0.23
T
Sift4G
Benign
0.36
T
Polyphen
0.0090
B
Vest4
0.067
MVP
0.30
MPC
0.047
ClinPred
0.015
T
GERP RS
1.2
Varity_R
0.030
gMVP
0.011
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs515726085; hg19: chr16-23647635; API